Drug cocktail prevents hepatitis B virus from recurring after liver transplant

Aiming to prevent recurrence of the hepatitis B virus (HBV) in post liver-transplant patients, UCLA researchers retrospectively reviewed survival rates of hepatitis B liver-transplantation patients. Their findings show that a combination of two drug therapies improved patient survival rates when compared to existing drug therapies given alone and that long-term treatment dramatically decreases recurrence of the disease.

The results, published in the May issue of the Annals of Surgery, showed the viral prophylaxis therapy or preventive treatment of hepatitis B immune globulin (HBIg) and lamivudine in combination prevents recurrence of HBV infection and lengthens patient survival rates following liver transplantation.

Researchers studied a total of 3,094 liver transplants performed at UCLA Medical Center from 1984 through April 2001. Of those, 191 transplant operations were performed on 166 patients afflicted with HBV cirrhosis. The patients were divided into four treatment groups: no prophylaxis, lamivudine monotherapy, HBIg monotherapy, or a lamivudine and HBIg combination.

When comparing the combination therapy to the monotherapy or no therapy, the HBV-free survival rates were considerably higher for patients who received the combination of HBIg and lamivudine. The one-year and three-year survival rates for the combination therapy were 92 percent and 81 percent, respectively. Survival rates for lamivudine alone were 72 percent and 62 percent. Survival rates for patients who were given HBIg alone were even lower at 45 percent and 36 percent.

Researchers also considered what effect therapy duration might have in HBV recurrence. With short-term HBIg monotherapy, HBV infection recurred in 60 percent of patients after transplant. With long term HBIg monotherapy, which is defined as greater than six months, 40 percent of the patients suffered HBV recurrence. But patients receiving long-term HBIg and lamivudine therapy had a dramatic redu

Contact: Kirsten Holguin
University of California - Los Angeles

Page: 1 2 3

Related medicine news :

1. Screening for osteoporosis prevents hip fractures in older adults
2. Understanding how prostaglandin prevents gut injury during radiation therapy
3. Exercise prevents Parkinsons symptoms in lab model mimicking human form of the disease
4. Study finds once-daily Valcyte prevents serious viral infection after kidney transplant
5. Enzyme prevents lung damage in premature infants
6. Enoxaparin prevents stillbirth in pregnant women with clotting disorder
7. New drug prevents arrhythmias that cause sudden cardiac death
8. Detecting vitamin B12 deficiency prevents anaemia and memory loss
9. Drug prevents diabetes recurrence after islet cell transplantation
10. Gene targeting prevents memory loss in Alzheimers disease model
11. Combined drug therapy prevents progression of prostate enlargement

Post Your Comments:

(Date:12/5/2018)... DEERFIELD, Ill. (PRWEB) , ... December 05, 2018 ... ... providing CRO, FSP, Strategic Resourcing, and Consulting services, announced its new office location ... location will accommodate organic growth of clinical trial operations in Europe and additional ...
(Date:12/5/2018)... ... 05, 2018 , ... Northcentral University (NCU) has today announced the launch of ... on a weekly rolling basis to registered nurses, the Master of Science in ... will prepare degree candidates to become leaders in the high-demand field. , ...
(Date:12/5/2018)... , ... December 05, 2018 , ... You can now ... LTRMN. , LTRMN , is a powerhouse in the cannabis industry with several ... True Terpenes is an industry leading, award winning , botanical terpene company ...
(Date:12/5/2018)... ... 2018 , ... Definitive Healthcare , the leading provider ... it was ranked #184 on Deloitte’s Technology Fast 500 list for 2018. The ... fields of technology, media, telecommunications, life science, and energy tech companies from 2014 ...
(Date:11/29/2018)... ... November 29, 2018 , ... ... month in the journal BMC Infectious Diseases published on August 29th, 2018 ... infectious viruses that can cause serious and in some cases life threatening ...
Breaking Medicine News(10 mins):
(Date:12/5/2018)... LOS ANGELES (PRWEB) , ... December 05, 2018 , ... ... known as Trivellini Long Hair, based on a version previously known as Mamba Nano, ... restoration. According to Dr. Trivellini, this version of “Trivellini system has the same capabilities ...
(Date:12/5/2018)... ... December 05, 2018 , ... HealthChannels, ... announced the hiring of Dr. Tony Andrulonis, MBA to lead company-wide operational performance ... over 20,000 medical scribes and support staff. Prior to joining HealthChannels, Andrulonis held ...
(Date:12/5/2018)... ... December 04, 2018 , ... ... for patient safety and quality. Today, the prestigious Leapfrog Group, a national nonprofit ... Hospital Carrollwood, Florida Hospital Heartland Medical Center Sebring, Florida Hospital Wesley Chapel and ...
Breaking Medicine Technology:
Cached News: